
1. exp biol med (maywood). 2014 apr;239(4):489-501. doi: 10.1177/1535370213520108.
epub 2014 feb 12.

attenuation endoplasmic reticulum stress pelizaeus-merzbacher disease an
anti-malaria drug, chloroquine.

morimura t(1), numata y, nakamura s, hirano e, gotoh l, goto yi, urushitani m,
inoue k.

author information: 
(1)department mental retardation birth defect research, national institute
of neuroscience, national center neurology psychiatry (ncnp), 4-1-1
ogawahigashi-machi, kodaira-shi, tokyo 187-8502, japan.

pelizaeus-merzbacher disease (pmd) hypomyelinating disorder caused the
duplication missense mutations proteolipid protein 1 (plp1) gene. plp1
missense proteins accumulate endoplasmic reticulum (er) premature
oligodendrocytes induce severe er stress followed apoptosis cells. 
here, demonstrate anti-malaria drug, chloroquine, decreases amount
of er-resident mutant plp1 containing alanine-243 valine (a243v)
substitution, induces severe pmd human. preventing mutant plp1
translation enhancing phosphorylation eukaryotic initiation factor
2 alpha, chloroquine ameliorated er stress induced mutant protein in
hela cells. chroloquine also attenuated er stress primary oligodendrocytes
obtained myelin synthesis deficit (msd) mice, carry plp1
mutation. spinal cords msd mice, chloroquine inhibited er stress and
upregulated expression marker genes mature oligodendrocytes.
chloroquine-mediated attenuation er stress observed hela cells treated 
with tunicamycin, n-glycosylation inhibitor, thapsigargin, a
sarco/er ca(2+)atpase inhibitor, confirms efficacy er stress
caused nascent proteins. findings indicate chloroquine er
stress attenuator potential use treating pmd possibly er
stress-related diseases.

doi: 10.1177/1535370213520108 
pmid: 24521562  [indexed medline]

